oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Tadalafil Aurovitas

The batch TGSD21011-A did not meet quality requirements due to a negative result for the parameter “release of tadalafil within 15 minutes”, which may affect treatment effectiveness. Potential effects: lack of therapeutic efficacy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Tadalafil Aurovitas
Risk Level
Medium
Manufacturer
Aurovitas Pharma Polska sp. z o.o. z siedzibą w Warszawie
Batch Number
TGSD21011-A
EAN Code
05909991392123
Recall Date
29.12.2023
View official statement

Important Information

What You Should Know

Recommendations

Patients may use the product according to the physician’s instructions; if they have any doubts about treatment effectiveness, they should contact their doctor or pharmacist.

Actions Taken

The product was sent for quality testing at the National Medicines Institute; based on the results, the Chief Pharmaceutical Inspector suspended its marketing nationwide with immediate effect, and lat...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The batch TGSD21011-A did not meet quality requirements due to a negative result for the parameter “release of tadalafil within 15 minutes”, which may affect treatment effectiveness. Potential effects: lack of therapeutic efficacy.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: TGSD21011-A

Related

Other Recalled Products